Source: Annual Congress 2006 - Inflammatory markers and experimental studies in occupational and environmental diseases
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Nemmar, M. F. Hoylaerts, P. H. M. Hoet, B. Nemery (Leuven, Belgium). Lung inflammation promotes arterial thrombosis via P-selectin: a study with carbon nanotubes in mice. Eur Respir J 2006; 28: Suppl. 50, 3621

Member's Comments

No comment yet.

Related content which might interest you: Endothelial-derived MIF contributes to pulmonary endothelial cell proliferation in human pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 HIV-associated pulmonary arterial hypertension onset is associated with the soluble CD14 level and inflammation related to monocyte activation by LPS translocation from the gut Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 MIF/CD74 contributes to the endothelial pro-inflammatory phenotype in pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Pulmonary artery endothelial cell exposure to hepcidin affects BMP-signalling; relevance to vascular remodelling in PAH Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension Year: 2020 Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 268s Year: 2005 MicroRNA-155 controls pulmonary artery fibroblast cell signalling and proliferation in a knockout mouse model: A role in pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Inflammation in pulmonary arterial hypertension Source: Eur Respir J 2003; 22: 358-363 Year: 2003 Inhibition of the Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling Year: 2006 CCR7 deficiency induces pulmonary hypertension involving perivascular leukocyte infiltration and inflammation Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010 VEGF reduces pulmonary hypertension and vascular remodeling in pulmonary fibrosis through reduced endothelial apoptosis Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 LATE-BREAKING ABSTRACT: TNFalpha mediates ectodomain shedding of BMPR-II: A potential role in pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Inflammatory mediators contribute to pulmonary arterial cell dysfunction in a pulmonary arterial hypertension patient with BMPR2 mutation Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Analysis of pulmonary endothelial microparticles, haemodynamics and functional class in pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Response to hypoxia of pulmonary arteries in chronic obstructive pulmonary disease: an in vitro study Source: Eur Respir J 2002; 20: 332-338 Year: 2002 Correlation of inhaled nitric-oxide induced reduction of pulmonary artery pressure and vascular changes Source: Eur Respir J 2002; 20: 52-58 Year: 2002 Vascular cell adhesion molecules-1 expression changes in lipopolysaccharide initiated pulmonary inflammation in endotoxin tolerance rats Source: Eur Respir J 2005; 26: Suppl. 49, 406s Year: 2005 Stabilised ferroportin activity affects pulmonary vascular cells responses: implications for pulmonary hypertension Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018 Endothelial cell mechanics are altered in pulmonary arterial hypertension (PAH) Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011